Reporting Requirements & MDSS
- MDSS Suspect/Active TB Case Reporting Guide: This guide reviews the process for reporting suspect and active cases of tuberculosis using the MDSS.
- 2020 RVCT Reference Manual: This manual was developed by the CDC to guide completion of the 2020 RVCT (Report of Verified Case of Tuberculosis) form.
- 2020 RVCT MDSS Training Slides: This PowerPoint presentation was created to teach those with MDSS access how to fill in the 2020 RVCT form accurately and completely in MDSS.
- 2020 RVCT MDSS Training Webinar: This webinar walks through the new RVCT form in MDSS with examples of how to use the new form.
Tuberculosis is a reportable disease, and physicians must report cases of TB within 24 hours of diagnosis or discovery to their local health department.
- Mycobacterium tuberculosis complex reporting and culture submission: A laboratory that receives a specimen from an individual that results in a laboratory report of Mycobacterium tuberculosis complex or yields a preliminary result* indicative of Mycobacterium tuberculosis complex is responsible for ensuring submission of the following:
- To the appropriate local health department – Report all preliminary results and any interpretation of those results
- To the MDHHS Laboratory – The first Mycobacterium tuberculosis complex isolate, or a subculture thereof, from the patient being tested for tuberculosis
- To the MDHHS Laboratory - Any Mycobacterium tuberculosis complex isolate or subculture thereof, from a follow-up specimen collected 90 days or more after the collection of the first Mycobacterium tuberculosis complex positive specimen. It is the responsibility of a clinical laboratory that receives a specimen found positive for Mycobacterium tuberculosis complex to ensure that the first available Mycobacterium tuberculosis complex isolate, whether cultured at the clinical laboratory or at a referral laboratory, is submitted to the Mycobacteriology Laboratory Unit at MDHHS, as soon as possible.
* Note: For the purpose of this rule, "preliminary result" includes, but is not limited to, results from nucleic acid amplification tests, nucleic acid or other genetic probe tests, chromatographic or other such tests that may be performed prior to final culture identification of a clinical specimen.
- Submission of Tuberculosis Laboratory Specimens: The clinical laboratory that initially receives any clinical specimen which yields Mycobacterium tuberculosis is responsible for ensuring that the following are submitted to the department:
- The first Mycobacterium tuberculosis isolate, or subculture thereof, from an individual with tuberculosis
- Any Mycobacterium tuberculosis isolate, or subculture thereof, from a follow-up specimen, collected 90 days or more after the collection of the first Mycobacterium tuberculosis positive specimen.